Ind-Swift Laboratories Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Navrattan Munjal
Chief executive officer
₹30.3m
Total compensation
| CEO salary percentage | 99.9% |
| CEO tenure | 29.7yrs |
| CEO ownership | 1.6% |
| Management average tenure | no data |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
There Are Some Reasons To Suggest That Ind-Swift Laboratories' (NSE:INDSWFTLAB) Earnings Are A Poor Reflection Of Profitability
Nov 20
Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors
Oct 20Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company
Jul 02Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story
May 21Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Apr 13Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?
Feb 17We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings
Dec 30These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹4b |
| Jun 30 2024 | n/a | n/a | ₹4b |
| Mar 31 2024 | ₹30m | ₹30m | ₹4b |
| Dec 31 2023 | n/a | n/a | ₹432m |
| Sep 30 2023 | n/a | n/a | ₹513m |
| Jun 30 2023 | n/a | n/a | ₹450m |
| Mar 31 2023 | ₹36m | ₹36m | ₹476m |
| Dec 31 2022 | n/a | n/a | ₹113m |
| Sep 30 2022 | n/a | n/a | -₹2m |
| Jun 30 2022 | n/a | n/a | -₹11m |
| Mar 31 2022 | ₹36m | ₹36m | -₹21m |
| Dec 31 2021 | n/a | n/a | ₹301m |
| Sep 30 2021 | n/a | n/a | ₹256m |
| Jun 30 2021 | n/a | n/a | ₹111m |
| Mar 31 2021 | ₹33m | ₹33m | -₹31m |
| Dec 31 2020 | n/a | n/a | ₹277m |
| Sep 30 2020 | n/a | n/a | ₹77m |
| Jun 30 2020 | n/a | n/a | -₹111m |
| Mar 31 2020 | ₹30m | ₹30m | -₹212m |
| Dec 31 2019 | n/a | n/a | -₹734m |
| Sep 30 2019 | n/a | n/a | -₹211m |
| Jun 30 2019 | n/a | n/a | -₹35m |
| Mar 31 2019 | ₹18m | ₹18m | ₹289m |
| Mar 31 2018 | ₹18m | ₹18m | ₹220m |
Compensation vs Market: Navrattan's total compensation ($USD356.73K) is above average for companies of similar size in the Indian market ($USD42.37K).
Compensation vs Earnings: Navrattan's compensation has been consistent with company performance over the past year.
CEO
Navrattan Munjal (72 yo)
29.7yrs
Tenure
₹30,308,000
Compensation
Mr. Navrattan R. Munjal has been a Managing Director of Ind-swift Laboratories Ltd. since March 29, 2001 and serves as its Chairman. He served as President of Indian Drug Manufacturers’ Association until J...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 29.7yrs | ₹30.31m | 1.56% ₹ 98.6m | |
| Joint MD & Whole Time Director | 21.4yrs | ₹37.88m | 0.69% ₹ 43.6m | |
| Executive Director | 14.8yrs | ₹15.16m | 0.77% ₹ 49.0m | |
| President of Operations & Special Assignments and Executive Director | 4.8yrs | ₹17.92m | 0.011% ₹ 724.6k | |
| Non-Executive Independent Director | 12.3yrs | ₹186.75k | no data | |
| Non-Executive Independent Director | 4.8yrs | ₹123.75k | no data | |
| Non-Executive Independent Woman Director | 5.6yrs | ₹85.50k | no data | |
| Non-Executive Independent Director | 3.5yrs | ₹148.50k | no data | |
| Independent Director | less than a year | no data | no data |
5.6yrs
Average Tenure
68yo
Average Age
Experienced Board: INDSWFTLAB's board of directors are considered experienced (5.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 16:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ind-Swift Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hitesh Kuvelkar | First Global Stockbroking (P) Ltd. |